• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forbes Norris Award

The Forbes Norris Award was established in 1994 to honour the legacy of Dr. Forbes “Ted” Norris (1928–1993), a neurologist who dedicated his life to supporting people living with ALS/MND. This prestigious award recognizes individuals whose work advances clinical care, research, and understanding of ALS/MND for the benefit of those living with the disease.

To be considered for the Forbes Norris Award, candidates must:

  • Play a major role in delivering outstanding ALS/MND patient care
  • Contribute significantly to medical literature in clinical management or basic science related to ALS/MND
  • Be part of a team engaged in ongoing research into ALS/MND care, management, or basic science

The award is presented annually during the opening ceremony of the MND Association’s International Symposium on ALS/MND. If no suitable candidate is nominated in a given year, the award will not be granted. Please note that current Board of Directors are not eligible for nomination.

The 2026 nomination period is open. The deadline to submit your nominations is Tuesday, September 15.

Forbes Norris Award Nomination Form

  • (No self-nominations please)
  • Accepted file types: doc, docx, pdf, Max. file size: 128 MB.
    Please use .doc, .docx, or .pdf
  • This field is for validation purposes and should be left unchanged.

Primary Sidebar

  • Olga, Argentina

    Olga, Argentina

  • Ana María Zavala, Mexico

    Ana María Zavala, Mexico

  • Chih Ching Darren Wong, Malaysia

    Chih Ching Darren Wong, Malaysia

  • Duncan Bayly, Australia

    Duncan Bayly, Australia

  • Lachlan Terry, Australia

    Lachlan Terry, Australia

  • Andrea Zicchieri, Italy

    Andrea Zicchieri, Italy
    AndreaZicchieri_conSLAncioItaly

  • Debbie Craghill, USA

    Debbie Craghill, USA

  • Carlos Alberto Báez Murillo, Colombia

    Carlos Alberto Báez Murillo, Colombia

  • Steven Gallagher, Canada

    Steven Gallagher, Canada

  • Laurie Petit-Jean, France

    Laurie Petit-Jean, France

  • Zelina Brito, Brazil

    Zelina Brito, Brazil

  • Ali Var, Turkey

    Ali Var, Turkey

  • Rolf Mauch, Switzerland

    Rolf Mauch, Switzerland

  • David Bishop, UK

    David Bishop, UK

  • Barry de Reuver, Netherlands

    Barry de Reuver, Netherlands

  • Irene McCaughey, Australia

    Irene McCaughey, Australia

  • Jette Odgaard Villemoes, Denmark

    Jette Odgaard Villemoes, Denmark

  • Maurice Leclerc, Canada

    Maurice Leclerc, Canada

  • Purningam Jacob, India

    Purningam Jacob, India

  • Eric Von Schaumburg, USA

    Eric Von Schaumburg, USA

  • Liong Ting Ngu, Malaysia

    Liong Ting Ngu, Malaysia

  • PALS and CALS, Singapore

    PALS and CALS, Singapore

  • John Sweeney, USA

    John Sweeney, USA

  • Steve Gallagher, Canada

    Steve Gallagher, Canada
    Picture1

  • Mikey Stone, ALS

    Mikey Stone, ALS

  • Glen Elison, USA

    Glen Elison, USA

  • Leon Ryba, Argentina

    Leon Ryba, Argentina

  • Margarita Pizarro, Argentina

    Margarita Pizarro, Argentina

  • Malu Araujo Ribeiro, Brazil

    Malu Araujo Ribeiro, Brazil

  • Teddy Hanono Annie, Mexico

    Teddy Hanono Annie, Mexico

  • Fernando Ocampo Cardona, Colombia

    Fernando Ocampo Cardona, Colombia

  • Shay Rishoni, Netherlands

    Shay Rishoni, Netherlands

  • Catherine Pearce, Australia

    Catherine Pearce, Australia

  • Ching-Liang Chu, Taiwan

    Ching-Liang Chu, Taiwan

  • Imelda Arenas, Colombia

    Imelda Arenas, Colombia

  • Dawn Morton, Scotland

    Dawn Morton, Scotland

  • Charlie Dourney, USA

    Charlie Dourney, USA

  • Hans Dieter Olszewski, Germany

    Hans Dieter Olszewski, Germany

  • Jeff Sutherland, Canada

    Jeff Sutherland, Canada
    jspic

  • Rob Tison, USA

    Rob Tison, USA

  • Wendy Hendrickson, USA

    Wendy Hendrickson, USA

  • Ian Roberts, Australia

    Ian Roberts, Australia

  • Rosie Riley, USA

    Rosie Riley, USA

  • Josée Kolijn-de Man, Netherlands

    Josée Kolijn-de Man, Netherlands

  • Chris McCauley, Canada

    Chris McCauley, Canada

  • Joyce Rusinak, USA

    Joyce Rusinak, USA

  • Jon Newsome, USA

    Jon Newsome, USA

  • Shera Mukherjee, India

    Shera Mukherjee, India

  • Frank Bos, Netherlands

    Frank Bos, Netherlands

  • Cath Muir, UK

    Cath Muir, UK
    Cath

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login